Physician profile
Ross Cole
NPI 1962865196
$2,314.70
in general payments reported to CMS, 2019-2025
10 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,261 · 2023: $521 · 2024: $118 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $1,417.91 | 2022-2025 | |
| Axogen | $460.94 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Smith+Nephew, INC. | $143.08 | 2022-2025 | Evos, Maverick, Ascension |
| Stryker Corporation | $96.25 | 2023-2025 | Crossfire, Insignia, Crossflow |
| Skeletal Dynamics INC | $76.33 | 2023 | Align, Geminus, Implate |
| Endo Pharmaceuticals INC. | $34.51 | 2023 | Xiaflex |
| Endo USA, INC. | $27.98 | 2025 | Xiaflex |
| Bioventus LLC | $22.67 | 2023 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $20.83 | 2025 | Krystexxa |
| Avanos Medical | $14.20 | 2023 | Grpro 2.1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.